Merrimack Pharmaceuticals, Inc. EPS - Earnings per Share 2010-2024 | MACK

Merrimack Pharmaceuticals, Inc. eps - earnings per share from 2010 to 2024. Eps - earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
Merrimack Pharmaceuticals, Inc. Annual EPS
2023 $-0.08
2022 $-0.11
2021 $-0.18
2020 $-0.23
2019 $-1.30
2018 $-3.03
2017 $35.67
2016 $-12.11
2015 $-13.29
2014 $-8.00
2013 $-13.20
2012 $-12.80
2011 $-76.70
2010 $-55.70
2009 $-72.80
Merrimack Pharmaceuticals, Inc. Quarterly EPS
2024-03-31 $13.93
2023-12-31 $-0.01
2023-09-30 $-0.02
2023-06-30 $-0.03
2023-03-31 $-0.02
2022-12-31 $-0.03
2022-09-30 $-0.03
2022-06-30 $-0.04
2022-03-31 $-0.01
2021-12-31 $-0.03
2021-09-30 $-0.04
2021-06-30 $-0.06
2021-03-31 $-0.05
2020-12-31 $-0.08
2020-09-30 $-0.08
2020-06-30 $-0.09
2020-03-31 $0.02
2019-12-31 $0.24
2019-09-30 $-0.05
2019-06-30 $-0.71
2019-03-31 $-0.78
2018-12-31 $-0.67
2018-09-30 $0.30
2018-06-30 $-1.33
2018-03-31 $-1.33
2017-12-31 $-0.92
2017-09-30 $0.24
2017-06-30 $38.62
2017-03-31 $-2.27
2016-12-31 $-2.48
2016-09-30 $-2.33
2016-06-30 $-4.00
2016-03-31 $-3.30
2015-12-31 $-4.19
2015-09-30 $-3.80
2015-06-30 $-2.10
2015-03-31 $-3.20
2014-12-31 $-0.90
2014-09-30 $-2.70
2014-06-30 $-1.70
2014-03-31 $-2.70
2013-12-31 $-3.30
2013-09-30 $-3.90
2013-06-30 $-3.10
2013-03-31 $-2.90
2012-12-31 $13.30
2012-09-30 $-2.50
2012-06-30 $-2.20
2012-03-31 $-21.40
2011-12-31 $-17.60
2011-09-30 $-18.10
2011-06-30 $-27.60
2011-03-31 $-13.50
2010-12-31 $-16.30
2010-09-30 $-13.30
2010-06-30 $-13.00
2010-03-31 $-13.10
2009-12-31 $0.00